查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1547380

全球外泌體技術市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Exosome Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2032年，全球外泌體技術市場的市場規模將從2023年的6,642萬美元達到近5,1004萬美元，2024-2032年研究期間複合年成長率為25.42%。

外泌體技術專注於外泌體的利用，外泌體是細胞釋放的小細胞外囊泡，在細胞間通訊中發揮不可或缺的作用。這些囊泡攜帶蛋白質、脂質和遺傳物質，影響各種生理和病理過程。它包括它們的分離、表徵以及在診斷和治療中的應用。在診斷中，外泌體可以作為癌症和神經退化性疾病的生物標記。治療方法被探索用於藥物輸送和再生醫學，因為它們可以將治療分子輸送到特定的目標細胞。這些技術的進步為個人化醫療和新穎的治療策略帶來了希望。

市場動態

人們對外泌體在診斷和治療方面的潛力越來越感興趣，這正在推動外泌體技術市場的成長。外泌體作為生物分子的天然載體，提供了一種非侵入性的疾病檢測和監測手段，在癌症診斷和其他醫學領域尤其有價值。分離和表徵技術的進步提高了基於外泌體的應用的功效和可靠性，進一步推動了市場成長。慢性病負擔的增加以及對有效治療方案的需求也促進了市場的成長。此外，生物技術公司和研究機構對研發的大量投資正在加速創新並擴大外泌體產品的潛在應用。監管部門的批准和對臨床試驗的支持為外泌體技術的商業化提供了有利的環境。人們越來越關注個人化醫療，即基於外泌體的診斷和治療可以根據個別患者的情況進行客製化，這是推動市場成長的另一個因素。此外，外泌體由於能夠跨越生物屏障運輸治療劑，在藥物遞送系統中的潛力引起了人們的廣泛關注和投資，從而促進了外泌體技術市場的強勁成長。然而，大規模生產、隔離技術標準化和法規核准流程的挑戰可能會阻礙未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球外泌體技術市場的各個細分市場進行了包容性評估。外泌體技術產業的成長和趨勢為本研究提供了整體方法。

市場區隔

外泌體技術市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按外泌體類型

  • 裝載貨物（胜肽、SIRNA、mRNA、miRNA、蛋白質、化學物質、其他）
  • 非貨物

按細胞來源

  • HEK293細胞
  • 間質幹細胞
  • 血小板
  • 紅血球
  • 自然殺手細胞
  • 其他

按申請

  • 治療學（腫瘤學、神經退化性疾病、心血管疾病、傳染病、化妝品、其他）
  • 診斷

按最終用戶

  • 醫療保健提供者
  • 製藥與生物技術公司
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲外泌體技術市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。外泌體技術市場的主要參與者包括Aegle Therapeutics、Aruna Bio Inc.、Bio-Techne Corporation、Carmine Therapeutics Inc.、Codiak BioSciences Inc.、Creative Biolabs、Danaher Corporation (Beckman Coulter Inc.)、Fujifilm Holdings Corporation、NOVADIP Biosciences SA 、OmniSpirant Limited、Thermo Fisher Scientific Inc。以及其他進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：外泌體技術 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 外泌體類型的市場吸引力分析
    • 按細胞來源分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球外泌體技術市場分析：按外泌體類型

  • 按外泌體類型概述
  • 依外泌體類型進行歷史和預測數據分析
  • 裝載貨物（胜肽、SIRNA、mRNA、miRNA、蛋白質、化學物質、其他）
  • 非貨物

第 6 章：全球外泌體技術市場分析：依細胞來源分類

  • 按細胞來源概述
  • 按細胞源進行歷史和預測數據分析
  • HEK293細胞
  • 間質幹細胞
  • 血小板
  • 紅血球
  • 自然殺手細胞
  • 其他

第 7 章：全球外泌體技術市場分析：依應用分類

  • 概述：按應用
  • 歷史與預測資料分析：按應用分類
  • 治療學（腫瘤學、神經退化性疾病、心血管疾病、傳染病、化妝品、其他）
  • 診斷

第 8 章：全球外泌體技術市場分析：依最終使用者分類

  • 最終用戶概述
  • 最終用戶的歷史和預測數據分析
  • 醫療保健提供者
  • 製藥與生物技術公司
  • 其他

第 9 章：全球外泌體技術市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：外泌體技術公司的競爭格局

  • 外泌體技術市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Aegle Therapeutics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Aruna Bio Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Techne Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Carmine Therapeutics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Codiak BioSciences Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Creative Biolabs
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher Corporation (Beckman Coulter Inc)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Fujifilm Holdings Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • NOVADIP Biosciences SA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • OmniSpirant Limited
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11215742

The global demand for Exosome Technologies Market is presumed to reach the market size of nearly USD 510.04 Million by 2032 from USD 66.42 Million in 2023 with a CAGR of 25.42% under the study period 2024-2032.

Exosome technologies focus on the utilization of exosomes, which are small extracellular vesicles released by cells that play an integral role in cell-to-cell communication. These vesicles carry proteins, lipids, and genetic material, influencing various physiological and pathological processes. It encompasses their isolation, characterization, and application in diagnostics and therapeutics. In diagnostics, exosomes can be biomarkers for cancer and neurodegenerative disorders. Therapeutics are explored for drug delivery and regenerative medicine, as they can deliver therapeutic molecules to specific target cells. Advances in these technologies hold promise for personalized medicine and novel treatment strategies.

MARKET DYNAMICS

The increasing interest in exosomes for their potential in diagnostics and therapeutics is driving the growth of the exosome technologies market. Exosomes, as natural carriers of biomolecules, offer a non-invasive means of disease detection and monitoring, which is particularly valuable in cancer diagnostics and other medical fields. Advancements in isolation and characterization techniques enhance the efficacy and reliability of exosome-based applications, further propelling market growth. The rising burden of chronic diseases and the need for effective treatment options also boost market growth. Furthermore, significant investments in research and development by biotech companies and research institutions are accelerating innovations and expanding the potential applications of exosome-based products. Regulatory approvals and support for clinical trials provide a conducive environment for the commercialization of exosome technologies. The increasing focus on personalized medicine, where exosome-based diagnostics and therapeutics can be tailored to individual patient profiles, is another factor driving market growth. Additionally, the potential of exosomes in drug delivery systems, due to their ability to transport therapeutic agents across biological barriers, garners significant attention and investment, contributing to the robust growth of the exosome technologies market. However, challenges in large-scale production, standardization of isolation techniques, and regulatory approval processes may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Exosome Technologies. The growth and trends of Exosome Technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Exosome Technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Exosome Type

  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others)
  • Non-cargo

By Cell Source

  • HEK293 Cells
  • MSCs
  • Platelets
  • Erythrocytes
  • Natural Killer Cells
  • Others

By Application

  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others)
  • Diagnostics

By End-user

  • Health Care Providers
  • Pharmaceutical & Biotechnology Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Exosome Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Exosome Technologies market include Aegle Therapeutics, Aruna Bio Inc., Bio-Techne Corporation, Carmine Therapeutics Inc., Codiak BioSciences Inc., Creative Biolabs, Danaher Corporation (Beckman Coulter Inc), Fujifilm Holdings Corporation, NOVADIP Biosciences S.A., OmniSpirant Limited, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EXOSOME TECHNOLOGIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Exosome Type
    • 3.7.2 Market Attractiveness Analysis By Cell Source
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY EXOSOME TYPE

  • 5.1. Overview By Exosome Type
  • 5.2. Historical and Forecast Data Analysis By Exosome Type
  • 5.3. Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Historic and Forecast Sales By Regions
  • 5.4. Non-cargo Historic and Forecast Sales By Regions

6. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY CELL SOURCE

  • 6.1. Overview By Cell Source
  • 6.2. Historical and Forecast Data Analysis By Cell Source
  • 6.3. HEK293 Cells Historic and Forecast Sales By Regions
  • 6.4. MSCs Historic and Forecast Sales By Regions
  • 6.5. Platelets Historic and Forecast Sales By Regions
  • 6.6. Erythrocytes Historic and Forecast Sales By Regions
  • 6.7. Natural Killer Cells Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Historic and Forecast Sales By Regions
  • 7.4. Diagnostics Historic and Forecast Sales By Regions

8. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-user
  • 8.2. Historical and Forecast Data Analysis By End-user
  • 8.3. Health Care Providers Historic and Forecast Sales By Regions
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EXOSOME TECHNOLOGIES COMPANIES

  • 10.1. Exosome Technologies Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EXOSOME TECHNOLOGIES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Aegle Therapeutics
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Aruna Bio Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bio-Techne Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Carmine Therapeutics Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Codiak BioSciences Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Creative Biolabs
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Danaher Corporation (Beckman Coulter Inc)
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Fujifilm Holdings Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. NOVADIP Biosciences S.A.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. OmniSpirant Limited
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Thermo Fisher Scientific Inc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Exosome Type (USD MN)
  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Market Sales By Geography (USD MN)
  • Non-cargo Market Sales By Geography (USD MN)
  • Analysis By Cell Source (USD MN)
  • HEK293 Cells Market Sales By Geography (USD MN)
  • MSCs Market Sales By Geography (USD MN)
  • Platelets Market Sales By Geography (USD MN)
  • Erythrocytes Market Sales By Geography (USD MN)
  • Natural Killer Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Health Care Providers Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Exosome Technologies Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Exosome Technologies Report
  • Market Research Process
  • Market Research Methodology
  • Global Exosome Technologies Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Exosome Type
  • Market Attractiveness Analysis By Cell Source
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Exosome Type (USD MN)
  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Market Sales By Geography (USD MN)
  • Non-cargo Market Sales By Geography (USD MN)
  • Global Market Analysis By Cell Source (USD MN)
  • HEK293 Cells Market Sales By Geography (USD MN)
  • MSCs Market Sales By Geography (USD MN)
  • Platelets Market Sales By Geography (USD MN)
  • Erythrocytes Market Sales By Geography (USD MN)
  • Natural Killer Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Health Care Providers Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.